CSLZ alivia la inflamación asociada a la colitis mediante la inhibición de las vías PI3K/Akt y MAPK, subrayando su potencial como un agente terapéutico novedoso para la colitis ulcerosa.
Building similarity graph...
Analyzing shared references across papers
Loading...
Guangtao Zhang
Zhengxian Gao
Tianjie Xie
Combinatorial Chemistry & High Throughput Screening
Shenzhen University
Shenzhen University Health Science Center
Peking University Shenzhen Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhang et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d893406c1944d70ce04429 — DOI: https://doi.org/10.2174/0113862073403084251212071505